Molecular responses in e19a2
BCR-ABL1
chronic myeloid leukemia
Leuk Res Rep
.
2020 Mar 12:13:100195.
doi: 10.1016/j.lrr.2020.100195.
eCollection 2020.
Authors
Laura Kearney
1
,
Mireille Crampe
1
,
Eibhlin Conneally
2
,
Janusz Krawczyk
3
,
Senthil Kumar
4
,
Philip T Murphy
5
,
Vitaliy Mykytiv
6
,
Mary-Frances Ryan
7
,
Stephen E Langabeer
1
Affiliations
1
Cancer Molecular Diagnostics, Trinity Translational Medicine Institute, St. James's Hospital, Dublin, D08 W9RT, Ireland.
2
Department of Haematology, St. James's Hospital, Dublin, Ireland.
3
Department of Haematology, Galway University Hospital, Galway, Ireland.
4
Department of Haematology, University Hospital Waterford, Waterford, Ireland.
5
Department of Haematology, Beaumont Hospital, Dublin, Ireland.
6
Department of Haematology, Cork University Hospital, Cork, Ireland.
7
Department of Haematology, University Hospital Limerick, Limerick, Ireland.
PMID:
32211287
PMCID:
PMC7082598
DOI:
10.1016/j.lrr.2020.100195
No abstract available
Keywords:
BCR-ABL1; Chronic myeloid leukemia; Molecular response; e19a2.